Universität zu Köln

2020

Westin, Jason, Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, McGuirk, Joseph, Holte, Harald, Waller, Edmund, Jaglowski, Samantha, Bishop, Michael, Andreadis, Charalambos, Foley, Stephen Ronan, Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan, Teshima, Takanori, Schuster, Stephen, Bachanova, Veronika, Maziarz, Richard, Van Besien, Koen, Izutsu, Koji, Kersten, Marie Jose, Magenau, John, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Han, Xia, Tiwari, Ranjan, Agoulnik, Sergei, Elderjou, Lamis, Pacaud, Lida Bubuteishvili and Salles, Gilles (2020). Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy iN Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial. Bone Marrow Transplant., 55 (SUPPL 1). S. 48 - 52. LONDON: SPRINGERNATURE. ISSN 1476-5365

2018

Schuster, Stephen J., Bishop, Michael R., Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, Waller, Edmund K., Holte, Harald, McGuirk, Joseph P., Jaglowski, Samantha, Tobinai, Kensei, Andreadis, Charalambos, Fleury, Isabelle, Mielke, Stephan, Teshima, Takanori, Westin, Jason R., Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Magenau, John M., Wagner-Johnston, Nina D., Kato, Koji, Kersten, Marie Jose, Van Besien, Koen, Chu, Jufen, Jary, Aline, Anak, Ozlem, Salles, Gilles and Maziarz, Richard Thomas T. (2018). Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2017

Schuster, Stephen, Bishop, Michael R., Tam, Constantine, Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph, Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason, Fleury, Isabelle, Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M., Holte, Harald, Anak, Oezlem, Pacaud, Lida, Awasthi, Rakesh, Tai, Feng, Salles, Gilles and Maziarz, Richard T. (2017). Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)-An Interim Analysis. Clin. Lymphoma Myeloma Leuk., 17. S. S373 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

2016

O'Brien, Susan, Jones, Jeffrey A., Coutre, Steven E., Mato, Anthony R., Hillmen, Peter, Tam, Constantine ORCID: 0000-0002-9759-5017, Osterborg, Anders, Siddiqi, Tanya ORCID: 0000-0001-5292-8298, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael J., Call, Timothy G., Brown, Jennifer R., Stevens-Brogan, Michelle, Li, Yunfeng, Clow, Fong, James, Danelle F., Chu, Alvina D., Hallek, Michael and Stilgenbauer, Stephan (2016). Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study. Lancet Oncol., 17 (10). S. 1409 - 1419. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

2015

Stilgenbauer, Stephan, Jones, Jeffrey A., Coutre, Steven, Mato, Anthony R., Hillmen, Peter, Tam, Constantine, Osterborg, Anders, Siddiqi, Tanya, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael, Call, Timothy G., Brown, Jennifer R., Li, Yunfeng, Eckert, Karl, Chang, Betty Y., James, Danelle F., Chu, Alvina D., Hallek, Michael and O'Brien, Susan (2015). Outcome of Ibrutinib Treatment by Baseline Genetic Features in Patients with Relapsed or Refractory CLL/SLL with del17p in the Resonate-17 Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2014

O'Brien, Susan, Jones, Jeffrey A., Coutre, Steven, Mato, Anthony R., Hillmen, Peter, Tam, Constantine, Osterborg, Anders, Siddiqi, Tanya, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael, Call, Timothy G., Brown, Jennifer R., Stevens-Brogan, Michelle, Li, Yunfeng, Fardis, Maria, Clow, Fong, James, Danelle F., Chu, Alvina D., Hallek, Michael and Stilgenbauer, Stephan (2014). Efficacy and Safety of Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia with 17p Deletion: Results from the Phase II RESONATE (TM)-17 Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020